These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 18565458)

  • 61. [Predictive value of typical cataplexy+ DQB1*0602 positive to hypocretin-1 reduction in cerebrospinal fluid in patients with narcolepsy].
    Chang Y; Dong XS; Li J; Zhang XZ; Yan H; Zhang W; Zhao L; Zuo YH; Yu YB; Dou YL; Feng JJ; Han F
    Zhonghua Yi Xue Za Zhi; 2018 Oct; 98(40):3253-3257. PubMed ID: 30392291
    [No Abstract]   [Full Text] [Related]  

  • 62. Hypocretin/orexin, sleep and narcolepsy.
    Hungs M; Mignot E
    Bioessays; 2001 May; 23(5):397-408. PubMed ID: 11340621
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Narcolepsy and other non-SAS hypersomnia in sleep breathing disorders clinic.
    Banno K; Shiomi T; Sasanabe R; Hasegawa R; Otake K; Yamakawa H; Kobayashi T; Horiba K; Nishino S
    Psychiatry Clin Neurosci; 2001 Jun; 55(3):203-4. PubMed ID: 11422842
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Narcolepsy--new implications of molecular biology].
    Knudsen S; Jennum PJ
    Ugeskr Laeger; 2006 Oct; 168(43):3699-704. PubMed ID: 17069732
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Rapid eye movement sleep behavior disorder and rapid eye movement sleep without atonia in narcolepsy.
    Dauvilliers Y; Jennum P; Plazzi G
    Sleep Med; 2013 Aug; 14(8):775-81. PubMed ID: 23219054
    [TBL] [Abstract][Full Text] [Related]  

  • 66. CSF hypocretin measures in patients with obstructive sleep apnea.
    Kanbayashi T; Inoue Y; Kawanishi K; Takasaki H; Aizawa R; Takahashi K; Ogawa Y; Abe M; Hishikawa Y; Shimizu T
    J Sleep Res; 2003 Dec; 12(4):339-41. PubMed ID: 14633246
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Incidence of narcolepsy in Norwegian children and adolescents after vaccination against H1N1 influenza A.
    Heier MS; Gautvik KM; Wannag E; Bronder KH; Midtlyng E; Kamaleri Y; Storsaeter J
    Sleep Med; 2013 Sep; 14(9):867-71. PubMed ID: 23773727
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Developmental changes in CSF hypocretin-1 (orexin-A) levels in normal and genetically narcoleptic Doberman pinschers.
    John J; Wu MF; Maidment NT; Lam HA; Boehmer LN; Patton M; Siegel JM
    J Physiol; 2004 Oct; 560(Pt 2):587-92. PubMed ID: 15308685
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Sleepiness that cannot be overcome: narcolepsy and cataplexy.
    Han F
    Respirology; 2012 Nov; 17(8):1157-65. PubMed ID: 22471619
    [TBL] [Abstract][Full Text] [Related]  

  • 70. CSF orexin levels of Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy and corticobasal degeneration.
    Yasui K; Inoue Y; Kanbayashi T; Nomura T; Kusumi M; Nakashima K
    J Neurol Sci; 2006 Dec; 250(1-2):120-3. PubMed ID: 17005202
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Lower wake resting sympathetic and cardiovascular activities in narcolepsy with cataplexy.
    Donadio V; Liguori R; Vandi S; Pizza F; Dauvilliers Y; Leta V; Giannoccaro MP; Baruzzi A; Plazzi G
    Neurology; 2014 Sep; 83(12):1080-6. PubMed ID: 25098533
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hypocretin-1 (orexin A) deficiency in acute traumatic brain injury.
    Baumann CR; Stocker R; Imhof HG; Trentz O; Hersberger M; Mignot E; Bassetti CL
    Neurology; 2005 Jul; 65(1):147-9. PubMed ID: 16009905
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Studies of humoral immunity to preprohypocretin in human leukocyte antigen DQB1*0602-positive narcoleptic subjects with cataplexy.
    Black JL; Silber MH; Krahn LE; Avula RK; Walker DL; Pankratz VS; Fredrickson PA; Slocumb NL
    Biol Psychiatry; 2005 Sep; 58(6):504-9. PubMed ID: 16043129
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hypocretin-1 deficiency in a girl with ROHHAD syndrome.
    Dhondt K; Verloo P; Verhelst H; Van Coster R; Overeem S
    Pediatrics; 2013 Sep; 132(3):e788-92. PubMed ID: 23940246
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The neurobiology of hypocretins (orexins), narcolepsy and related therapeutic interventions.
    Zeitzer JM; Nishino S; Mignot E
    Trends Pharmacol Sci; 2006 Jul; 27(7):368-74. PubMed ID: 16766052
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A patient with anti-aquaporin 4 antibody who presented with recurrent hypersomnia, reduced orexin (hypocretin) level, and symmetrical hypothalamic lesions.
    Nozaki H; Shimohata T; Kanbayashi T; Sagawa Y; Katada S; Satoh M; Onodera O; Tanaka K; Nishizawa M
    Sleep Med; 2009 Feb; 10(2):253-5. PubMed ID: 18226957
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Undetectable CSF level of orexin A (hypocretin-1) in a HLA-DR2 negative patient with narcolepsy-cataplexy.
    Dalal MA; Schuld A; Pollmächer T
    J Sleep Res; 2002 Sep; 11(3):273. PubMed ID: 12220324
    [No Abstract]   [Full Text] [Related]  

  • 78. Hypocretin-1 (orexin-A) levels in human lumbar CSF in different age groups: infants to elderly persons.
    Kanbayashi T; Yano T; Ishiguro H; Kawanishi K; Chiba S; Aizawa R; Sawaishi Y; Hirota K; Nishino S; Shimizu T
    Sleep; 2002 May; 25(3):337-9. PubMed ID: 12003164
    [TBL] [Abstract][Full Text] [Related]  

  • 79. CSF hypocretin-1 levels in schizophrenics and controls: relationship to sleep architecture.
    Nishino S; Ripley B; Mignot E; Benson KL; Zarcone VP
    Psychiatry Res; 2002 May; 110(1):1-7. PubMed ID: 12007588
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Sleep disturbances and hypocretin deficiency in Niemann-Pick disease type C.
    Vankova J; Stepanova I; Jech R; Elleder M; Ling L; Mignot E; Nishino S; Nevsimalova S
    Sleep; 2003 Jun; 26(4):427-30. PubMed ID: 12841368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.